Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis

被引:0
|
作者
Xinyu Ma
Rui Tang
Mei Luo
Zhuotong Zeng
Yaqian Shi
Bingsi Tang
Rong Xiao
机构
[1] The Second Xiangya Hospital,Department of Dermatology
[2] Central South University,Department of Rheumatology and Immunology
[3] The Second Xiangya Hospital,Department of Neurosurgery
[4] Central South University,undefined
[5] Xiangya Hospital,undefined
[6] Central South University,undefined
来源
Clinical Rheumatology | 2021年 / 40卷
关键词
Cyclophosphamide; Interstitial lung disease; Meta-analysis; Mycophenolate mofetil; Systemic sclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3185 / 3193
页数:8
相关论文
共 50 条
  • [41] Effectiveness of bosentan in the treatment of systemic sclerosis-related digital ulcers: Systematic review and meta-analysis
    Hosseinbalam, Marziyeh
    Nouri, Rasool
    Farajzadegan, Ziba
    Mottaghi, Peyman
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2023, 28 (01):
  • [42] The Efficacy of Treatment for Systemic Sclerosis Interstitial Lung Disease: Results from a Meta-Analysis
    Broad, Kathleen
    Pope, Janet
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2586 - 2587
  • [43] The efficacy of treatment for systemic sclerosis interstitial lung disease: Results from a meta-analysis
    Broad, Kathleen
    Pope, Janet
    [J]. MEDICAL SCIENCE MONITOR, 2010, 16 (09): : RA187 - RA190
  • [44] Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trial
    Nupoor Acharya
    Shefali Khanna Sharma
    Debashish Mishra
    Sahajal Dhooria
    Varun Dhir
    Sanjay Jain
    [J]. Rheumatology International, 2020, 40 : 703 - 710
  • [45] Effects of Mycophenolate Mofetil on Pulmonary Lung Function in Interstitial Lung Disease of Systemic Sclerosis.
    Pham, Michael
    Griffing, W. Leroy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S742 - S742
  • [46] Update on morbidity and mortality in systemic sclerosis-related interstitial lung disease
    Volkmann, Elizabeth R.
    Fischer, Aryeh
    [J]. JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2021, 6 (01) : 11 - 20
  • [47] Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
    Mango, Robert L.
    Matteson, Eric L.
    Crowson, Cynthia S.
    Ryu, Jay H.
    Makol, Ashima
    [J]. LUNG, 2018, 196 (04) : 409 - 416
  • [48] Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension
    Vakhshoorzadeh, Jasmine
    Lui, Justin K.
    Sangani, Ruchika A.
    Trojanowski, Marcin A.
    Bujor, Andreea M.
    LaValley, Michael P.
    Klings, Elizabeth S.
    [J]. RESPIRATORY MEDICINE, 2023, 216
  • [49] Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
    Lee, Shih-Ching
    Huang, Chen-Hao
    Oyang, Yen-Jen
    Huang, Hsuan-Cheng
    Juan, Hsueh-Fen
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [50] Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
    Robert L. Mango
    Eric L. Matteson
    Cynthia S. Crowson
    Jay H. Ryu
    Ashima Makol
    [J]. Lung, 2018, 196 : 409 - 416